Literature DB >> 14740129

[Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

G Otto1, J Thies, M Hoppe-Lotichius, F Bittinger, M B Pitton, A Hadian.   

Abstract

The increasingly performed en bloc resection of liver and hilar tumor has contributed to the improvement of long-term survival in patients with hilar cholangiocarcinoma. Based on preoperative definition of operative strategy we tried to avoid any traumatization of the hilar region. Between September 1997 and September 2002, 82 patients with hilar cholangiocarcinoma were treated at our department. Three patients were excluded from any surgery. The resection rate was 75% (59 of 79); 79% (38 of 48) of en bloc resections of the hilar tumor and adjacent liver were formally curative. The hospital mortality was 7%. The 1- and 3-year survival rates of patients after explorative laparotomy, palliative and curative resection was 27 and 7%, 67 and 26%, 89 and 45% ( p<0.001), respectively. The 1- and 3-year survival rates of patients after en bloc resection were 78 and 49%, respectively. In patients with formally curative en bloc resection ( n=38), the 3-year survival rate was 63%; in patients with N0/R0 resection ( n=31) it was 71%. Lymph node involvement proved to be the only independent prognostic marker if patients who underwent hilar and en bloc resection were included in the multivariate analysis. The R situation was the only significant predictor for patients after en bloc resection. These data justify the extended diagnostic work-up and the principal liver resection in hilar cholangiocarcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 14740129     DOI: 10.1007/s00104-003-0747-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  24 in total

1.  Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience.

Authors:  M F Gerhards; T M van Gulik; L T de Wit; H Obertop; D J Gouma
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

2.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

3.  Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; Y Shimizu; A Kato; S Nakamura; H Omoto; N Nakajima; F Kimura; T Suwa
Journal:  Surgery       Date:  1998-02       Impact factor: 3.982

Review 4.  [Malignant tumors of the hepatic bifurcation--results of surgical therapy and prognostic factors].

Authors:  K T Beckurts; A H Hölscher; T H Bauer; J R Siewert
Journal:  Chirurg       Date:  1997-04       Impact factor: 0.955

5.  Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; T Okaya; K Shinmura; N Nakajima
Journal:  J Am Coll Surg       Date:  1999-12       Impact factor: 6.113

6.  [Combined portal vein and liver resection for biliary cancer].

Authors:  M Nagino; Y Nimura
Journal:  Nihon Geka Gakkai Zasshi       Date:  2001-11

7.  Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival.

Authors:  Lorenzo Capussotti; Andrea Muratore; Roberto Polastri; Alessandro Ferrero; Paolo Massucco
Journal:  J Am Coll Surg       Date:  2002-11       Impact factor: 6.113

8.  Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.

Authors:  Hiroshi Shimada; Itaru Endo; Yoshiro Fujii; Osamu Kunihiro; Kuniya Tanaka; Koichiro Misuta; Sinji Togo
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

9.  One hundred and eleven liver resections for hilar bile duct cancer.

Authors:  S G Lee; Y J Lee; K M Park; S Hwang; P C Min
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

Review 10.  Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach.

Authors:  K D Lillemoe; J L Cameron
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000
View more
  3 in total

1.  [Surgical therapy of hilar cholangiocarcinoma].

Authors:  H Lang; G M Kaiser; T Zöpf; G C Sotiropoulos; A Frilling; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

2.  The role of liver transplantation in the treatment of hilar cholangiocarcinoma.

Authors:  Hauke Lang; Georgios C Sotiropoulos; Gernot M Kaiser; Ernesto P Molmenti; Massimo Malagó; Christoph E Broelsch
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

3.  Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.

Authors:  Armin Thelen; Arne Scholz; Christoph Benckert; Maik Schröder; Wilko Weichert; Bertram Wiedenmann; Peter Neuhaus; Sven Jonas
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.